Results 231 to 240 of about 2,626,240 (311)

Microalbuminuria and glycated hemoglobin in children with type 1 diabetes mellitus [PDF]

open access: hybrid, 2014
Magdy Omar   +3 more
openalex   +1 more source

Post‐authorisation safety study to assess the risk of urinary tract cancer in people with type 2 diabetes initiating empagliflozin: A multi‐country European study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims This study aimed to assess the risk of urinary tract cancers (UTCs), including bladder and renal cancers, in people with type 2 diabetes (T2D) initiating empagliflozin compared with people initiating any dipeptidyl peptidase‐4 inhibitor (DPP‐4i) in the United Kingdom (UK), Sweden, and Finland.
Niklas Schmedt   +6 more
wiley   +1 more source

Can fasting plasma glucose and glycated hemoglobin levels predict oral complications following invasive dental procedures in patients with type 2 diabetes mellitus? A preliminary case-control study

open access: gold, 2013
Ana Carolina Fragoso Motta   +4 more
openalex   +1 more source

Real‐world evaluation of automated insulin delivery therapy in type 1 diabetes: A multicentre study across regional and metropolitan Queensland, Australia

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Background Automated insulin delivery (AID) systems, which integrate continuous glucose monitoring (CGM) with automated insulin dosing, have emerged as a transformative therapy. However, real‐world data on AID effectiveness, particularly in regional Australia, remain limited.
Akash Konantambigi   +11 more
wiley   +1 more source

Efficacy and safety of once‐weekly tirzepatide in Japanese participants with type 2 diabetes who have obesity or overweight: Subpopulation analysis of the SURMOUNT‐2 trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aim To assess the efficacy and safety of once‐weekly tirzepatide in Japanese participants with obesity and type 2 diabetes (T2D). Materials and Methods This subpopulation analysis of 41 Japanese participants from three clinical trial sites in the SURMOUNT‐2 trial evaluated the efficacy and safety of tirzepatide as an adjunct to lifestyle ...
Toshimasa Yamauchi   +4 more
wiley   +1 more source

Molten Globule of Hemoglobin Proceeds into Aggregates and Advanced Glycated End Products

open access: gold, 2013
Afshin Iram   +5 more
openalex   +2 more sources

Comparable Dietary Patterns Describe Dietary Behavior across Ethnic Groups in the Netherlands, but Different Elements in the Diet Are Associated with Glycated Hemoglobin and Fasting Glucose Concentrations [PDF]

open access: bronze, 2015
Louise H. Dekker   +9 more
openalex   +1 more source

Current treatment guidelines and glycated haemoglobin goals for type 2 diabetes: Which patients are most likely to benefit from fixed‐ratio basal insulin glucagon‐like peptide‐1 receptor agonist combinations?

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Basal insulin and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are available in two fixed‐ratio combinations (FRCs) for the treatment of type 2 diabetes (T2D), insulin degludec with liraglutide and insulin glargine with lixisenatide.
Kevin Cowart, Nicholas W. Carris
wiley   +1 more source

Home - About - Disclaimer - Privacy